Joshua Levy, M.D.

National Institute on Deafness and Other Communication Disorders (NIDCD)

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Joshua Levy, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:38 UTC. Open this list on ClinicalTrials.gov

Ph3
NCT06461949 · Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
National Institute on Deafness and Other Communication Disorders (NIDCD) · withdrawn · Allergic Fungal Rhinosinusitis (AFRS), Chronic Rhinosinusitis (CRS), Asthma · principal investigator
N/A
NCT00001604 · Genetic Linkage Studies of Stuttering
National Institute on Deafness and Other Communication Disorders (NIDCD) · completed · Stuttering · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name.